DCM
CORT icon

Dupont Capital Management’s Corcept Therapeutics CORT Stock Holding History

Dupont Capital Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,258
Closed -$299K – 1664
2022
Q1 		$299K Sell
13,258
-1,173
-8% -$25K 0.01% 922
2021
Q4 		$286K Sell
14,431
-5,754
-29% -$117K 0.01% 992
2021
Q3 		$397K Sell
20,185
-13,111
-39% -$274K 0.01% 978
2021
Q2 		$733K Hold
33,296
– – 0.02% 768
2021
Q1 		$792K Sell
33,296
-6,829
-17% -$182K 0.02% 689
2020
Q4 		$1.05M Sell
40,125
-2,995
-7% -$63.1K 0.02% 541
2020
Q3 		$751K Buy
43,120
+8,953
+26% +$143K 0.02% 601
2020
Q2 		$575K Sell
34,167
-3,051
-8% -$42.9K 0.01% 707
2020
Q1 		$443K Sell
37,218
-54,909
-60% -$680K 0.01% 709
2019
Q4 		$1.11M Buy
92,127
+8,272
+10% +$115K 0.03% 538
2019
Q3 		$1.19M Sell
83,855
-8,990
-10% -$110K 0.03% 476
2019
Q2 		$1.03M Hold
92,845
– – 0.02% 538
2019
Q1 		$1.09M Hold
92,845
– – 0.02% 525
2018
Q4 		$1.24M Hold
92,845
– – 0.03% 479
2018
Q3 		$1.3M Hold
92,845
– – 0.03% 502
2018
Q2 		$1.46M Hold
92,845
– – 0.03% 454
2018
Q1 		$1.53M Sell
92,845
-24,694
-21% -$458K 0.04% 403
2017
Q4 		$2.12M Hold
117,539
– – 0.05% 340
2017
Q3 		$2.27M Hold
117,539
– – 0.05% 326
2017
Q2 		$1.39M Buy
+117,539
New +$1.28M 0.03% 452

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dupont Capital Management's CORT Position: Q2 2022 in Review

Dupont Capital Management sold out of Corcept Therapeutics (CORT) in Q2 2022, closing a stake of 13,258 shares — an estimated $299K sold.

Dupont Capital Management first reported a position in CORT in Q2 2017 and held it in 20 quarters. The position peaked at $2.27M in Q3 2017. 225 funds tracked by Wall St. Rank hold CORT as of Q2 2022.

  • Dupont Capital Management reported no remaining Corcept Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Dupont Capital Management sold 13,258 Corcept Therapeutics shares in Q2 2022, an estimated $299K.
  • Dupont Capital Management first reported a position in Corcept Therapeutics in Q2 2017 and held it in 20 quarters.
  • Dupont Capital Management's Corcept Therapeutics position peaked at $2.27M in Q3 2017.
  • 225 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2022.

Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.